These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 15817453)

  • 1. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
    Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW
    J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
    Qiu G; Hill JS
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI.
    Taylor JM; Borthwick F; Bartholomew C; Graham A
    Cardiovasc Res; 2010 Jun; 86(3):526-34. PubMed ID: 20083572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages.
    Wang W; Song W; Wang Y; Chen L; Yan X
    J Cardiovasc Pharmacol; 2013 Jul; 62(1):90-8. PubMed ID: 23846804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
    Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation.
    Rowe AH; Argmann CA; Edwards JY; Sawyez CG; Morand OH; Hegele RA; Huff MW
    Circ Res; 2003 Oct; 93(8):717-25. PubMed ID: 14512442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
    Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages.
    Jiang Z; Sang H; Fu X; Liang Y; Li L
    Biotechnol Appl Biochem; 2015; 62(6):840-7. PubMed ID: 25496323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor {gamma}-liver X receptor {alpha}-ABCA1 pathway.
    Xia M; Hou M; Zhu H; Ma J; Tang Z; Wang Q; Li Y; Chi D; Yu X; Zhao T; Han P; Xia X; Ling W
    J Biol Chem; 2005 Nov; 280(44):36792-801. PubMed ID: 16107338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.
    Zanotti I; Potì F; Favari E; Steffensen KR; Gustafsson JA; Bernini F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):395-401. PubMed ID: 16415093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin up-regulates expressions of peroxisome proliferator-activated receptor γ, liver X receptor α, and ATP binding cassette transporter A1 genes and increases cholesterol efflux in human macrophage cell line.
    Lee SM; Moon J; Cho Y; Chung JH; Shin MJ
    Nutr Res; 2013 Feb; 33(2):136-43. PubMed ID: 23399664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux.
    Zhou X; Yin Z; Guo X; Hajjar DP; Han J
    J Biol Chem; 2010 Feb; 285(9):6316-26. PubMed ID: 20037141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation.
    Okuhira K; Fitzgerald ML; Tamehiro N; Ohoka N; Suzuki K; Sawada J; Naito M; Nishimaki-Mogami T
    J Biol Chem; 2010 May; 285(21):16369-77. PubMed ID: 20348106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
    Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
    Li M; Liu Y; Dutt P; Fanburg BL; Toksoz D
    Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L463-71. PubMed ID: 17545489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages.
    Qiu G; Hill JS
    J Lipid Res; 2007 Oct; 48(10):2112-22. PubMed ID: 17644777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells.
    Genvigir FD; Rodrigues AC; Cerda A; Arazi SS; Willrich MA; Oliveira R; Hirata MH; Dorea EL; Bernik MM; Curi R; Hirata RD
    Pharmacogenomics; 2010 Sep; 11(9):1235-46. PubMed ID: 20860464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual mechanisms of ABCA1 regulation by geranylgeranyl pyrophosphate.
    Gan X; Kaplan R; Menke JG; MacNaul K; Chen Y; Sparrow CP; Zhou G; Wright SD; Cai TQ
    J Biol Chem; 2001 Dec; 276(52):48702-8. PubMed ID: 11641412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.